Format

Send to

Choose Destination
Rheumatol Int. 2018 Feb;38(2):319. doi: 10.1007/s00296-017-3918-8.

Correction to: Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety.

Author information

1
Division of Rheumatology, University of California, San Francisco, 513 Parnassus Avenue, San Francisco, CA, 94143, USA. Milena.Gianfrancesco@ucsf.edu.
2
Division of Rheumatology, University of California, San Francisco, 513 Parnassus Avenue, San Francisco, CA, 94143, USA.
3
Veterans Affairs Medical Center, San Francisco, San Francisco, USA.
4
Department of Medicine, California Pacific Medical Center, San Francisco, USA.
5
Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, USA.
6
Institute for Computational Health Sciences, University of California, San Francisco, San Francisco, USA.
7
Center for Healthcare Value, Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco, USA.

Abstract

The given and family name of a co-author R. Adams Dudley was swapped in the published article. The correct given name is R. Adams and the family name is Dudley.

PMID:
29273937
DOI:
10.1007/s00296-017-3918-8

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center